Navigation Links
Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
Date:6/12/2013

working with customers to arrange for product return.

Anyone with an existing inventory of this particular Lot MM5767 of Warfarin 2 mg Tablets should stop use and distribution, quarantine the recalled lots immediately and call INMAR at 1-800-967-5952 between the hours of 7 a.m. to 4 p.m. CST, Monday through Friday, to arrange for their return. In case patients have tablets of this lot of product, make sure all the tablets are of the same size and if unsure, patients should consult their dispensing pharmacy.

If you have any question about product safety issue, then please call Zydus Pharmaceuticals Drug Safety/ Medical Affairs at 1-877-993-8779, Option# 2. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this particular lot of Warfarin 2 mg Tablets.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


'/>"/>
SOURCE Zydus Pharmaceuticals USA Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Zydus fait une percée avec LIPAGLYN, première NEC indienne mise sur le marché
2. Zydus Pioneers a Breakthrough With LIPAGLYN, Indias First NCE to Reach the Market
3. Zydus Demonstra Pioneirismo com o Inovador LIPAGLYN, Primeiro NCE da Índia a Entrar no Mercado
4. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
5. Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard
6. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients with Sickle Cell Disease
7. Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel
8. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus
10. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
11. Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  Building on the momentum ... the leading provider of medical alert systems, has announced aggressive ... Services (HCBS) program and Managed Care business models. ... Texas , Tennessee and ... awarded 16 regional contracts to span statewide coverage in each ...
(Date:3/30/2015)... Research and Markets ( ... the "Urological Catheters - Global Strategic ... This report analyzes the worldwide ... and US$ Thousands by the following Product ... Catheters), and Urinary Catheters (Foley Catheters, Intermittent ...
(Date:3/30/2015)... 30, 2015  Rigrodsky & Long, P.A.: , ... ASPX )? , Did you purchase any of ... you think the proposed buyout price is too low? ... Rigrodsky & Long, P.A. announces that it ... of Auspex Pharmaceuticals, Inc. ("Auspex" or the "Company") (NASDAQ GM: ...
Breaking Medicine Technology:MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2
... 2007 - Array BioPharma Inc.,(Nasdaq: ARRY) today announced that its Chief ... Emerging,Growth Conference on July 10 in New York City. The public ... BioPharma website. -0-, ,Event: ... Robert E. Conway, Chief Executive Officer, Array, ...
... July 03, 2007,/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd , ... French, Rosetta Genomics,President, will present at CE Unterberg, ... at 11:00 am EST at,the Mandarin Oriental Hotel ... of the presentation will be available on,the "Investors" ...
Cached Medicine Technology:Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
(Date:3/30/2015)... Wright & Schulte LLC, who is currently representing ... of Syngenta corn lawsuits now pending in ... District of Kansas, have risen sharply since the proceeding ... released by the U.S. Judicial Panel on Multidistrict Litigation ... are now consolidated in the federal litigation, all of ...
(Date:3/30/2015)... York (PRWEB) March 30, 2015 A ... filed in California Superior Court on behalf of a ... birth defect after his mother was prescribed the anti-nausea ... the March 6th filing in Alameda Superior Court, the ... and vomiting that she experienced in the early months ...
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an ... six new treatment options for dealing with stubborn, unwanted fat. ... topical product. The other three technologies use devices to deliver ... freezing cold ( CoolSculpting ) to kill fat cells. (see: ... us to permanently remove unwanted fat," says Dr. Simon Ourian, ...
(Date:3/30/2015)... 30, 2015 In a recent report ... Governor Chris Christie is championing effective drug and alcohol ... is scrambling to recover funds to stabilize the addiction ... for victims of drug and alcohol addiction. Harbor Village ... plagued by substance use disorders in New Jersey, in ...
(Date:3/30/2015)... This report studies the global pharmacovigilance and ... of 2014 to 2019. This market is expected ... 2014 to 2019. , Further Inquiry @ ... pharmacovigilance and drug safety software market has been ... functionality, namely, adverse event reporting software, drug safety ...
Breaking Medicine News(10 mins):Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4
... BIO International Convention , ... Atlanta, GA (PRWEB) May 31, 2009 -- ... BIO International Convention. The leading hair regeneration company joined more ... largest annual event for the biotechnology industry, held May 18-21 at the ...
... with advanced disease, , , SATURDAY, May 30 (HealthDay News) --A ... study. , Melanoma is the most serious type of skin ... are 65 percent and 16 percent, respectively. In 2009, an ... with melanoma and about 8,600 will die of the disease, ...
... points to estrogen,s potential role in the disease, experts ... current use of combined hormone replacement therapy (HRT) is ... diagnosed with non-small cell lung cancer, a new study ... less high in former smokers and least high in ...
... study presented on Saturday is embargoed until the time ... other studies is not embargoed , CAFFEINE SHOWN AS ... INHALER , An Indiana University study found that the ... reduce the symptoms of exercise induced asthma (EIA). ...
... longer-term study, researchers say , , SATURDAY, May 30 (HealthDay ... lung, breast and metastatic colorectal cancers, appears ineffective for ... trial,s lead author called "disappointing." , "There,s no sense ... drama. We failed to provide patients with a novel ...
... SCOTTSDALE, Ariz., May 30 MedTrust Online LLC simultaneously ... of financing, released a more powerful search engine for ... another world class oncologist to its Advisory Board. ... Online is rapidly becoming the leading source for cancer ...
Cached Medicine News:Health News:Aderans Research BIO International Press Release 2Health News:Aderans Research BIO International Press Release 3Health News:Experts Optimistic About Melanoma Vaccine 2Health News:HRT Ups Death Risk for Women With Lung Cancer 2Health News:HRT Ups Death Risk for Women With Lung Cancer 3Health News:Indiana U. research at the American College of Sports Medicine conference 2Health News:Indiana U. research at the American College of Sports Medicine conference 3Health News:Indiana U. research at the American College of Sports Medicine conference 4Health News:Indiana U. research at the American College of Sports Medicine conference 5Health News:Indiana U. research at the American College of Sports Medicine conference 6Health News:Avastin Shows No Benefit Against Early Stage Colon Cancer 2Health News:Avastin Shows No Benefit Against Early Stage Colon Cancer 3Health News:Avastin Shows No Benefit Against Early Stage Colon Cancer 4Health News:MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework 2
Headlight module is mounted on UltraLite Plus headband or sweatband....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
Medicine Products: